cystine
brushite
Ca.oxalate monohydrate
Ca.oxalate dihydrate
D. Ca.oxalate dihydrate
0 10%
10 20%
20 30%
30 40%
best treated by total parathyroidectomy
first-time stone formers are at a 50% risk for recurrence
males have higher recurrence rate than females
stone formers produce stones of the same type every time
piezoelectric
electrohydraulic
electromagnetic
microexplosive
watchful waiting
open surgical correction
IVU with possible endoscopic ureteral stenting
perc. nephrostomy tube insertion
orthophosphates may have a role in the treatment
hyperparathyroidectomy and levothyroxine replacement is the optimum treatment
management includes Calcium chelating agent and repeat 24hr urine collection in 3 months
surgical excision of the adenoma(s) is the treatment of choice
ESWL
URS
PCNL
none of the above
Klebsiella pneumonia
Morganella morganii
Proteus mirabilis
all of the above
commonly unilateral
commonly due to repeated infections
urate stones are the second most common cause of staghorn calculi
ESWL monotherapy with ureteral stenting is the ideal treatment
when stones are multiple and/or recurrent
when stones form in childhood
in cases where nephrocalcinosis and urolithiasis are present
all of the above
dehydration
metabolic disorders
congenital anomalies
all of the above
have diagnostic hexagonal crystals
dont respond to ESWL therapy
are highly soluble in water
inherited in an autosomal recessive fashion
400 600 HU
600 800 HU
800 1000 HU
1000 1200 HU
because urine and body secretions are highly concentrated
due to renal leak hypercalciuria
as a result of distal renal tubular acidosis type I
because of reduced or absent of oxalobacter formigenes colonization
a stone in the lower calyx with a wide mouth of infundibulum and obtuse lower calyx to ureter angle
a stone in an anterior group calyceal diverticulum with thin overlying renal parenchyma
5 mm calcium-containing stone in an intrarenal pelvis and wide UPJ
6 years post anatrophic nephrolithotomy, recurrent mid calyceal stone
classical nucleation theory
heterogeneous nucleation
suspension solution
concentric lamination
α-Mercaptopropionylglycine
acetohydroxamic acid
carbonic anhydrase inhibitors
xanthine oxidase inhibitors
stones in a solitary kidney
ureteral stones causing bilateral obstructions
a kidney stone of ≥ 2.5 cm in size
all of the above
furosemide
tamsulosin
nifedipine
diclofenac
upper, lower, mid
lower, upper, mid
mid, upper, lower
mid, lower, upper
α-Mercaptopropionylglycine
d-Penicillamine
a & b
none of the above
the commonest to form staghorn giant calculi
formed by urease producing bacteria
antibiotics have a role in the treatment
form at the two extremes of urinary pH range
cysteine
urate
calcium
none of the above
form due to inspissated smegma
form due to stasis of urinary salts
cause inguinal lymphadenopathy
often associated with phimosis in uncircumcised males
Proteus mirabilis
E. coli
Pseudomonas aeruginosa
Staphylococcus epidermidis
placement of a percutaneous nephrostomy drain
surgical exploration and primary repair
conservative management
endoscopic retrograde ureteral stenting
matrix
indinavir
brushite
2,8 dihydroxyadenine
terminal ilium resection
liver transplantation
kidney transplantation
regular hemodialysis
urate
triple phosphate
oxalate monohydrate
matrix
by ensuring optimal coupling of the patient to the lithotripter
by running the treatment at a slower rate (60 shocks/min)
by running the treatment with general anesthesia
by all of the above
2 days
2 weeks
2 months
4 6 hrs.